<code id='FF8212B157'></code><style id='FF8212B157'></style>
    • <acronym id='FF8212B157'></acronym>
      <center id='FF8212B157'><center id='FF8212B157'><tfoot id='FF8212B157'></tfoot></center><abbr id='FF8212B157'><dir id='FF8212B157'><tfoot id='FF8212B157'></tfoot><noframes id='FF8212B157'>

    • <optgroup id='FF8212B157'><strike id='FF8212B157'><sup id='FF8212B157'></sup></strike><code id='FF8212B157'></code></optgroup>
        1. <b id='FF8212B157'><label id='FF8212B157'><select id='FF8212B157'><dt id='FF8212B157'><span id='FF8212B157'></span></dt></select></label></b><u id='FF8212B157'></u>
          <i id='FF8212B157'><strike id='FF8212B157'><tt id='FF8212B157'><pre id='FF8212B157'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:54
          Illustration of a road with a chasm in the middle, indicating the end of a deal or a problem with a deal
          Adobe

          A deal is never really done until it’s done.

          On Tuesday, two different proposed insurance plan acquisitions on different sides of the country called it quits — one of them for the second time.

          advertisement

          California-based Medicare Advantage insurer SCAN Group has been trying to buy CareOregon, an insurer offering coverage to half a million people in Oregon’s state health plan, since January 2023. National insurer Elevance has also been trying to buy Blue Cross and Blue Shield of Louisiana since last January. The on-again, off-again purchase was paused in September 2023 because of state regulators’ concerns, but was resubmitted with a slightly different plan in December.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          With FDA staff opposed to Sarepta therapy, top official intervened
          With FDA staff opposed to Sarepta therapy, top official intervened

          AlogosignoutsideoftheheadquartersofSareptaTherapeuticsinCambridge,Mass.KristofferTripplaar/SipaviaAP

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

          RubyWallauforSTATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne